Annals of Surgical Oncology

, Volume 7, Issue 1, pp 55–66 | Cite as

Hilar Cholangiocarcinoma: A Review and Commentary

  • Ronald S. Chamberlain
  • Leslie H. Blumgart
Original Article


Hilar cholangiocarcinoma is an uncommon cause of malignant biliary obstruction marked by local tumor spread for which surgery offers the only chance of cure. The diagnostic evaluation and surgical management of this disease continues to evolve. Although direct cholangiography and endoscopic biliary procedures have been used extensively to anatomically define the extent of tumor involvement, establish biliary decompression, and obtain histological confirmation of tumor, reliance on these invasive procedures is no longer necessary, and may be detrimental. Current noninvasive imaging technology permits accurate staging of the primary tumor and has improved patient selection for operative intervention without the need for invasive procedures. Overall survival has improved in accordance with an increasingly aggressive surgical approach. The propensity of this tumor for local invasion has led most experienced hepatobiliary centers to perform a partial hepatectomy in 50% to 100% of cases. Three-year survival rates of 35% to 50% can be achieved when negative histological margins are attained at the time of surgery. When resection is not feasible, either operative bilioenteric bypass or percutaneous transhepatic intubation can achieve significant palliation. There is no effective adjuvant therapy for this disease, and unless clear indications of unresectability exist, most patients should be considered for surgical exploration.


Surgery Hilar cholangiocarcinoma Bile duct cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kirschbaum JD, Kozoll DC. Carcinoma of the gall bladder and extrahepatic bile ducts. SGO 1941;73:740–753.Google Scholar
  2. 2.
    Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75:171–190.PubMedGoogle Scholar
  3. 3.
    Nakeeb A, Pitt HA, Sohn TA, Coleman J, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463–475.PubMedGoogle Scholar
  4. 4.
    Tompkins RK, Thomas D, Wile A, et al. Prognostic factors in bile duct carcinoma. Ann Surg 1981;194:447–455.PubMedGoogle Scholar
  5. 5.
    Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 552 carcinomas of the bile duct (gall bladder and periampullary excluded). Ann Surg 1991;213:236–241.PubMedGoogle Scholar
  6. 6.
    Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Prob Surg 1995;32:1–90.Google Scholar
  7. 7.
    Thuluvath PJ, Rai R, Vembrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306–315.PubMedGoogle Scholar
  8. 8.
    Blumgart LH, Benjamin IS. Cancer of the bile ducts. In: Blumgart LH, ed. Surgery of the Liver and Biliary Tract. 2nd ed. London:Churchill Livingstone, 1994:1051–1067.Google Scholar
  9. 9.
    Hadjis NS, Blenkharn JI, Alexander N, Benjamin IS, Blumgart LH. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 1990;107:597–604.PubMedGoogle Scholar
  10. 10.
    Burke E, Jarnigan WR, Hochwald SN, Pisters PWT, Fong Y, Blumgart LH. Hilar cholangiocarcinoma patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385–394.CrossRefPubMedGoogle Scholar
  11. 11.
    Hochwald SN, Burke E, Jarnigan WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:251–266.Google Scholar
  12. 12.
    Jarnigan WR, Burke E, Power C, Fong Y, Blumgart LH. Intrahepatic biliary enteric bypass provides effective palliation in selected patient with malignant obstruction at the hepatic duct confluence. Am J Surg 1998;175:453–460.Google Scholar
  13. 13.
    Karsten TM, Allema JH, Reinders M, et al. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur J Surg 1996;162:881–888.PubMedGoogle Scholar
  14. 14.
    McPherson GA, Benjamin IS, Hodgson HJ, Bowley NB, Allison DJ, Blumgart LH. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 1984;71:371–375.PubMedGoogle Scholar
  15. 15.
    Temudon T, Sarr MG, Douglas MG, Farnell MB. An argument against the routine percutaneous biopsy, ERCP, or biliary stent placement in patients with clinically resectable periampullary masses: a surgical perspective. Pancreas 1995;11:283–288.CrossRefGoogle Scholar
  16. 16.
    Heslin MJ, Brooks AD, Hochwald SN, Blumgart LH, Brennan MF. A preoperative biliary stent is associated with increased complications after pancreaticoduodenectomy. Arch Surg 1998;133:149–154.PubMedGoogle Scholar
  17. 17.
    Valek V, Ruzicka M. Preoperative drainage of the biliary tract in patients with obstructive jaundice. Rozhl Chir 1995;74:235–238.PubMedGoogle Scholar
  18. 18.
    Elyaderani MK, McDowell DE, Zimmermann B. Percutaneous transhepatic catheterization in reconstructive surgery of the biliary ducts. South Med J 1985;78:142–149.PubMedGoogle Scholar
  19. 19.
    Shaked A, Colonna JO, Goldstein L, Busuttil RW. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992;215:598–605.PubMedGoogle Scholar
  20. 20.
    Sako K, Seitzinger GL, Garside E. Carcinoma of the extra-hepatic bile ducts: review of the literature and report of six cases. Surgery 1957;41:416–437.PubMedGoogle Scholar
  21. 21.
    Kuwayti K, Baggenstoss AH, Stauffer MH, Preistley JI. Carcinoma of the major intrahepatic and extrahepatic bile ducts exclusive of the papilla of Vater. SGO 1957;104:357–366.PubMedGoogle Scholar
  22. 22.
    Weinbren K, Mutumm SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983;139:217–238.PubMedGoogle Scholar
  23. 23.
    Shimada H, Nimoto S, Matsuba A, et al. The infiltration of the bile duct carcinoma along the bile duct wall. Int Surg 1988;73:87–90.PubMedGoogle Scholar
  24. 24.
    Skamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct cancer: a histological analysis of 62 resected cases. Ann Surg 1998;227:405–411.Google Scholar
  25. 25.
    Gertsch P, Thomas P, Baer H, Lerut J, Zimmermann A, Blumgart LH. Multiple tumors of the biliary tract. Am J Surg 1990;159:386–388.PubMedGoogle Scholar
  26. 26.
    Stain SC, Baer HU, Dennison AR, Blumgart LH. Current management of hilar cholangiocarcinoma. SGO 1992;175:579–588.PubMedGoogle Scholar
  27. 27.
    Hann LE, Fong Y, Shriver CD, et al. Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability? J Ultrasound Med 1996;15:37–45.PubMedGoogle Scholar
  28. 28.
    Schwartz LH, Coakley FV, Sun Y, Blumgart LH, Fong Y, Panicek DM. Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol 1998;170:1491–1495.PubMedGoogle Scholar
  29. 29.
    Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 1996;201:347–351.PubMedGoogle Scholar
  30. 30.
    Lee MG, Lee HJ, Kim MH, et al. Extrahepatic biliary disease: 3D MR cholangiopancreatography. Radiology 1997;202:663–669.PubMedGoogle Scholar
  31. 31.
    Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991;161:57–62.CrossRefPubMedGoogle Scholar
  32. 32.
    Ryan ME. Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139–142.CrossRefPubMedGoogle Scholar
  33. 33.
    American Joint Committee on Cancer, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.Google Scholar
  34. 34.
    Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. SGO 1975;140:170–178.PubMedGoogle Scholar
  35. 35.
    Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31–38.PubMedGoogle Scholar
  36. 36.
    Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts: histologic types, stage of disease, grade, and survival. Cancer 1992;70:1498–1501.PubMedGoogle Scholar
  37. 37.
    Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 1996;224:628–638.PubMedGoogle Scholar
  38. 38.
    Chamberlain RS, Blumgart LH. The surgical approach to cholangiocarcinoma. Curr Med Lit Gastroenterol 1999;18:24–40.Google Scholar
  39. 39.
    Tsuzuki T, Ueda M, Kuramochi S, et al. Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival. Surgery 1990;108:495–501.PubMedGoogle Scholar
  40. 40.
    Baer HU, Stain S, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resection in hilar cholangiocarcinoma. Ann Surg 1993;217:20–27.PubMedGoogle Scholar
  41. 41.
    Nagorney DM, Donohue JH, Farnell M, Sckleck LD, Ilstrup DM. Outcomes after curative resection of cholangiocarcinoma. Arch Surg 1993;128:871–879.PubMedGoogle Scholar
  42. 42.
    Suigura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994;115:445–451.Google Scholar
  43. 43.
    Su C-H, Tsay S-H, Wu C-C, et al. Factors influencing postoperative morbidity, mortality, and survival after liver resection for hilar cholangiocarcinoma. Ann Surg 1996;223:384–394.PubMedGoogle Scholar
  44. 44.
    Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998;227:70–79.PubMedGoogle Scholar
  45. 45.
    Figueras J, Llado-Garriga L, Lama C, et al. Resection as elective treatment of hilar cholangiocarcinoma. Gastroenterol Hepatol 1998;21:218–223.PubMedGoogle Scholar
  46. 46.
    Nagino M, Nimura Y, Kamiya J, et al. Segmental liver resection for hilar cholangiocarcinoma. Hepatogastroenterology 1998;45:7–13.PubMedGoogle Scholar
  47. 47.
    Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998;123:131–136.CrossRefPubMedGoogle Scholar
  48. 48.
    Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990;14:535–544.PubMedGoogle Scholar
  49. 49.
    Ringe B, Witteking C, Bechstein WO, Buzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancies: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1988;209:88–98.CrossRefGoogle Scholar
  50. 50.
    Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26–34.PubMedGoogle Scholar
  51. 51.
    Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358–364.PubMedGoogle Scholar
  52. 52.
    Jeyarajah DR, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobil Pancreat Surg 1998;5:48–51.Google Scholar
  53. 53.
    Shapiro MJ. Management of malignant biliary obstruction: nonoperative and palliative techniques. Oncology 1995;9:493–496.PubMedGoogle Scholar
  54. 54.
    Schmassmann A, von Guten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996;91:654–659.PubMedGoogle Scholar
  55. 55.
    Pack BT, Islami AH. Tumors of the Liver. Berlin: Springer-Verlag, 1970.Google Scholar
  56. 56.
    Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995;82:1522–1555.PubMedGoogle Scholar
  57. 57.
    Leung JT, Kuan R. Intraluminal brachytherapy in the treatment of bile duct carcinomas. Australas Radiol 1997;41:151–154.PubMedGoogle Scholar
  58. 58.
    Vallis KA, Benjamin IS, Munro AJ, et al. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability. Radiother Oncol 1996;41:61–66.PubMedGoogle Scholar
  59. 59.
    McMasters KM, Tuttle TM, Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997;174:605–609.PubMedGoogle Scholar
  60. 60.
    Hishinuma S, Ogata Y, Matsui J, Ozawa I, Imura J. Preoperative radiotherapy for cancer of the extrahepatic bile duct. Am J Clin Oncol 1998;21:203–208.PubMedGoogle Scholar
  61. 61.
    Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998;82:2321–2325.PubMedGoogle Scholar
  62. 62.
    Patt YZ, Jones DV, Hoque A, et al. Phase II trial of intravenous fluorouracil and subcutaneous interferon alpha-2b for biliary tract cancer. J Clin Oncol 1996;14:2311–2315.PubMedGoogle Scholar
  63. 63.
    Ravry MJ, Omura GA, Bartolucci AA, Einhorn L, Kramer C, Davila E. Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial. Cancer Treat Res 1986;70:311–312.Google Scholar
  64. 64.
    Bukowski RM, Leichman LP, Rivkin SE. Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group Study. Eur J Cancer Clin Oncol 1983;19:721–723.PubMedGoogle Scholar
  65. 65.
    Ortner MA, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998;114:536–542.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2000

Authors and Affiliations

  1. 1.Department of Surgery, Montefiore Medical CenterAlbert Einstein College of MedicineBronx
  2. 2.Hepatobiliary Service, Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkNew York
  3. 3.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew York

Personalised recommendations